期刊文献+

解剖性肝中叶切除治疗中央型肝癌 被引量:7

Anatomical mesohepatectomy for central hepatocellular carcinoma
原文传递
导出
摘要 目的探讨解剖性肝中叶切除治疗中央型肝癌的可行性及近期疗效。方法回顾性分析2007年1月至2011年12月收治的85例原发性中央型肝癌(单发,无远处转移),按照手术方式分为解剖性肝中叶切除术组(A组)共36例,非解剖性肝中叶切除术组(B组)共49例,比较手术策略,术中情况,术后并发症及近期复发转移情况。结果2组术中出血量差异无统计学意义(P〉0.05);各组术中输血量差异无统计学意义(P〉0.05);A组术后住院时间及总住院费用明显优于B组(P〈0.05);A组手术时间较B组长,2组比较差异有统计学意义(P〈0.05);并发症发生人数和发生人次2组有明显统计学差异;A组复发转移7例,占该组的19.4%(7/36);而非解剖组复发转移20例,占该组的40.8%(20/49),2组比较差异有统计学意义(P〈0.05)。结论解剖性肝中叶切除具有手术打击小,术中出血少,术后渗出及并发症少,复发转移率低等优点,可作为治疗中央型肝癌的首选手术方式。 Objective To compare the efficacies of anatomic and nonanatomic mesohepatectomy for central type hepatocellular carcinoma. Methods The clinical data of 85 patients with central type hepatocellular carcinoma undergoing hepatectomies were retrospectively analysed. 36 patients underwent anatomic mesohepatectomy and the other 49 patients did nonanatomic mesohepatectomy. The operative time, intraoperative blood loss, incidence of postoperative complications, postoperative drainage volume, time to flatus and length of postoperative stay between the two groups were compared. Results There were no significant differences in the general condition, organ function, tumor size and location between the two groups before operation ( P 〉 0.05 ). The intraoperative blood loss, incidence of postoperative complications, drainage volume were significantly less but the operative time longer in anatomic mesohepatectomy group than nonanatomic hepatectomy group (P 〈 0. 05 ). No differences between the two groups were found in regard to the time for flatus and length of postoperative hospital stay ( P 〉 0. 05 ). Tumor recurrence developed in 7 cases in group A and 20 cases in group B ( P 〈 O. 05 ). Conclusions Anatomic mesobepatectomy has the advantages of less surgical trauma, less exudation and complications in patients with central type hepatocellular carcinoma.
出处 《中华普通外科杂志》 CSCD 北大核心 2014年第1期13-16,共4页 Chinese Journal of General Surgery
关键词 肝细胞 肝切除术 Carcinoma,hepatocellular Hepatectomy
  • 相关文献

参考文献10

  • 1McClusky DA 3rd, Skandalakis LJ, Colbom GL, et al. Hepatic surgery and hepatic surgical anatomy: historical partners in progress[J]. World J Surg, 1997, 21(3) :330- 342. 被引量:1
  • 2Yamanaka J, Saito S, Fujimoto J. Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma [ J ]. World J Surg, 2007, 31 ( 6 ) : 1249- 1255. 被引量:1
  • 3Tanaka K, Shimada H, Matsumoto C, et al. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma [ J ]. Surgery, 2008,143 ( 5 ) : 607 -615. 被引量:1
  • 4Tanaka S, Mogushi K, Yasen M, et al. Surgical contribution to recurrence-free survival in patients with macrovascular invasion- negative hepatocellular carcinoma [ J ]. J Am Coll Surg, 2009, 208 (3) :368-374. 被引量:1
  • 5Zhou Y, Sui C, Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review[ J]. World J Surg Oncol,2010, 8:55. 被引量:1
  • 6Wakai T, Shirai Y, Sakata J, et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma [ J ]. Ann Surg Oncol, 2007,14 (4) : 1356-1365. 被引量:1
  • 7Zhou Y, Xu D, Wu L, et al. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma [ J ]. Langenbecks Arch Surg, 2011, 396 ( 7 ) : 1109 -1117. 被引量:1
  • 8Machado MA, Kalil AN. Glissonian approach for laparoscopic mesohepatectomy[J]. Surg Endosc ,2011,25 :2020-2022. 被引量:1
  • 9吴力群,张顺,郭卫东,曹景玉,王祖森,胡维昱,韩冰,张斌,邱法波.伴有肝硬化门静脉高压症的肝细胞癌患者肝切除术的并发症和预后分析[J].中华普通外科杂志,2013,28(7):492-496. 被引量:16
  • 10朱民,刘崇忠,胡三元,朱健康,刘凤悦,仲明惟.肝段血流阻断技术在肝癌患者精准肝段切除中的应用[J].中华普通外科杂志,2013,28(7):523-525. 被引量:15

二级参考文献19

  • 1中华外科学会肝脏外科学组.原发性肝癌外科治疗方法的选择(2004年第一次修订)[J].中华普通外科杂志,2005,20(4):262-264. 被引量:12
  • 2陈焕伟,刘允怡,甄作均,苏树英.超声引导下以肝段为本的解剖性肝切除术[J].中华肝胆外科杂志,2006,12(6):378-380. 被引量:17
  • 3Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the study of the liver. J Hepatol, 2001, 35: 421-430. 被引量:1
  • 4Choi GH, Park JY, Hwang HK, et al. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int, 2011,31:485-493. 被引量:1
  • 5Yang LY, Fang F, Ou DP, et al. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg, 2009, 249 : 118- 123. 被引量:1
  • 6Fujisaki S, Miyake H, Amano S, et al. Influence of the extent of hepatectomy on the portal hypertensive state in patients with hepatoma. Hepatogastroenterology, 1999,46:2490-2494. 被引量:1
  • 7Capussotti L, Ferrero A, Vigano L, et al. Portal hypertension: contraindication to liver surgery.'? World J Surg, 2006, 30 : 992- 999. 被引量:1
  • 8Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersp|enism. J Am Coll Surg, 2000, 190:446-450. 被引量:1
  • 9Liu HS, Zhang AQ, Qian NS, et al. Postoperative transarterial chemoembolization benefits patients with high /-glutamyl transferase levels after curative hepatectomy for hcpatocellular carcinoma: a survival stratification analysis. Tohoku J Exp Mcd, 2012, 227:269-280. 被引量:1
  • 10Fan ST. Precise hepatectomy guided by the middle hepatic vein. Hepatobiliary Pancreat Dis Int, 2007,6:430-434. 被引量:1

共引文献29

同被引文献49

  • 1梅铭惠,陈谦,杨景红,邱维家,袁晟光,吕军,喻亚群,翁俊,刘杰.肝癌淋巴结转移——外科治疗面临的挑战之一[J].中华普通外科学文献(电子版),2007,1(2):89-92. 被引量:9
  • 2Grazi GL, Cescon M, Ravaioli M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics : evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre[ J ]. Aliment Pharmacol Ther, 2003, 17 ( Suppl 2 ) : 119-129. 被引量:1
  • 3Imai K, Beppu T, Chikamoto A, et al. Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy[J]. Hepatol Res,2014,44(14) :335-345. 被引量:1
  • 4Eisele RM, Chopra SS, Lock JF, et al. Treatment of recurrent hepatocellular carcinoma confined to the liver with repeated resection and radiofrequency ablation: a single centre experience [ J]. Technol Health Care,2013,21 ( 1 ) : 9-18. 被引量:1
  • 5Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study [ J ]. Ann Surg 0ncol,2013,15(12) :3484-3493. 被引量:1
  • 6Chart AC, Poon RT, Cheung TY, et al. Survival analysis of re- resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma [ J ]. World J Surg, 2012, 36 (1) :151-156. 被引量:1
  • 7Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for repeat hepateetomy in patients with recurrent hepatoeellular carcinoma[J]. Ann Surg,2003,238(5) :703-710. 被引量:1
  • 8Poon RT, Fan ST, Wong J, et al. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [J]. Ann Surg,2000,232( 1 ) :10-24. 被引量:1
  • 9Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatoeellular carcinoma :current status and therapeutic targets[J]. Semin Cancer Biol.2011.21 ( 1 ) : 35- 43. 被引量:1
  • 10Okuwaki Y, Nakazawa T, Kokubu S, et al. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocenular carcinoma [ J ]. Am J Gastroentero1,2009,104 ( 11 ) :2747-2753. 被引量:1

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部